Exactly.
So instead of just talking up the PRV, how about including more upfront info. Such as:
The RPDD is welcome recognition from the FDA. While a PRV would provide considerable value to the company, we have every intention to continue to rapidly advance RC220 in our lead indications. As such we expect that the award of a PRV unlikely due to seeking FDA approval in other indications before paediac AML.
Exactly.So instead of just talking up the PRV, how about...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.77 |
Change
0.015(0.86%) |
Mkt cap ! $300.6M | |||
| Open | High | Low | Value | Volume |
| $1.82 | $1.82 | $1.77 | $91.78K | 51.30K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 31147 | $1.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.80 | 8318 | 1 |
View Market Depth
| Last trade - 15.59pm 10/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |